Cite
Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study.
MLA
Borte, Michael, et al. “Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: The FIGARO Study.” Journal of Clinical Immunology, vol. 43, no. 6, Aug. 2023, pp. 1259–71. EBSCOhost, https://doi.org/10.1007/s10875-023-01470-2.
APA
Borte, M., Hanitsch, L. G., Mahlaoui, N., Fasshauer, M., Huscher, D., Speletas, M., Dimou, M., Kamieniak, M., Hermann, C., Pittrow, D., & Milito, C. (2023). Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study. Journal of Clinical Immunology, 43(6), 1259–1271. https://doi.org/10.1007/s10875-023-01470-2
Chicago
Borte, Michael, Leif G. Hanitsch, Nizar Mahlaoui, Maria Fasshauer, Dörte Huscher, Matthaios Speletas, Maria Dimou, et al. 2023. “Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: The FIGARO Study.” Journal of Clinical Immunology 43 (6): 1259–71. doi:10.1007/s10875-023-01470-2.